LCAR- F33S cells intravenous infusion
LB2502-0001
Unknown mab active
Quick answer
LCAR- F33S cells intravenous infusion for Relapsed/Refractory Multiple Myeloma(MM) is a Unknown program (mab) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- China SXT Pharmaceuticals
- Indication
- Relapsed/Refractory Multiple Myeloma(MM)
- Phase
- Unknown
- Modality
- mab
- Status
- active